Quick Comparison

Methylene BlueMethylene Blue
Half-Life5-6 hours5-6 hours
Typical DosageNootropic dose: 0.5-2 mg/kg body weight (typically 30-60 mg for most adults). Pharmaceutical grade USP only — never use industrial or aquarium-grade. Start at the lowest dose. Turns urine blue/green (harmless).Nootropic dose: 0.5-2 mg/kg body weight (typically 30-60 mg for most adults). Pharmaceutical grade USP only — never use industrial or aquarium-grade. Start at the lowest dose. Turns urine blue/green (harmless).
AdministrationOral (solution, capsules). Must be pharmaceutical/USP grade. Sublingual for faster absorption.Oral (solution, capsules). Must be pharmaceutical/USP grade. Sublingual for faster absorption.
Research Papers10 papers10 papers
Categories

Mechanism of Action

Methylene Blue

Methylene blue has a unique property: it acts as an alternative electron carrier in the mitochondrial electron transport chain, cycling between oxidized (blue) and reduced (leuco) forms. It can accept electrons from Complex I (NADH) and donate them directly to cytochrome c, bypassing dysfunctional Complex II and III—maintaining ATP production when mitochondria are damaged or in hypoxic conditions. Methylene blue inhibits nitric oxide synthase (NOS), reducing NO production and the formation of peroxynitrite (ONOO-), a potent oxidant that damages mitochondria. It acts as a redox cycler with antioxidant properties and may enhance cytochrome c oxidase (Complex IV) activity. At low doses, it inhibits tau protein aggregation and tau-tau interactions (relevant to Alzheimer's pathology) and may improve mitochondrial respiration through multiple mechanisms.

Methylene Blue

Methylene blue has a unique property: it acts as an alternative electron carrier in the mitochondrial electron transport chain, cycling between oxidized (blue) and reduced (leuco) forms. It can accept electrons from Complex I (NADH) and donate them directly to cytochrome c, bypassing dysfunctional Complex II and III—maintaining ATP production when mitochondria are damaged or in hypoxic conditions. Methylene blue inhibits nitric oxide synthase (NOS), reducing NO production and the formation of peroxynitrite (ONOO-), a potent oxidant that damages mitochondria. It acts as a redox cycler with antioxidant properties and may enhance cytochrome c oxidase (Complex IV) activity. At low doses, it inhibits tau protein aggregation and tau-tau interactions (relevant to Alzheimer's pathology) and may improve mitochondrial respiration through multiple mechanisms.

Risks & Safety

Methylene Blue

Common

Blue/green discoloration of urine and potentially skin at higher doses, nausea, headache.

Serious

Serotonin syndrome risk when combined with SSRIs, SNRIs, or MAOIs — DO NOT combine. Contraindicated in G6PD deficiency (can cause hemolytic anemia).

Rare

Confusion, shortness of breath, chest pain.

Methylene Blue

Common

Blue/green discoloration of urine and potentially skin at higher doses, nausea, headache.

Serious

Serotonin syndrome risk when combined with SSRIs, SNRIs, or MAOIs — DO NOT combine. Contraindicated in G6PD deficiency (can cause hemolytic anemia).

Rare

Confusion, shortness of breath, chest pain.

Full Profiles